Milk Thistle Fatigue Meta-analysis: What the Evidence Says
Milk Thistle Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixe
Quick Answer
Milk Thistle Fatigue Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 research article, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Milk Thistle Fatigue Meta-analysis: What the Evidence Says
Quick Answer
Milk Thistle Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 research article, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study | research article | 4 | 2026-01-01 | 10.7573/dic.2025-12-5 |
| Mechanistic Insights into the Anti-Inflammatory and Anti-Proliferative Effects of Selected Medicinal Plants in Endometriosis | preclinical study | 4 | 2025-11-12 | 10.3390/ijms262210947 |
What The Sources Report
- The term ‘metabolic dysfunction-associated fatty liver disease' was coined in 2020 to stress this relationship, but it lacked global consensus. [Sukeepaisarnjaroen Wattana (2026); evidence level 4]
- To reduce stigma and improve diagnostic clarity, the expert panel endorsed the term ‘metabolic dysfunction-associated steatotic liver disease' (MASLD) in 2023;given the nearly identical prevalence rates for NAFLD (38.01%) and MASLD (37.9%), indicating substantial diagnostic overlap,the term MASLD is now preferred. [Sukeepaisarnjaroen Wattana (2026); evidence level 4]
- The disease significantly impairs patients' quality of life, often manifesting as dysmenorrhea, dyspareunia, and chronic fatigue, and has been associated with comorbid inflammatory and autoimmune disorders including rheumatoid arthritis, psoriasis, and migraine. [Burdan Oliwia (2025); evidence level 4]
- Many hypotheses have been proposed to explain the development of endometriosis, and they all essentially boil down to a dysregulated hormonal balance and increased levels of pro-inflammatory cytokines. [Burdan Oliwia (2025); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For milk thistle fatigue meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Sukeepaisarnjaroen Wattana (2026). Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study. DOI: 10.7573/dic.2025-12-5. PMCID: PMC13082349. PMID: 41993723. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13082349/
- Burdan Oliwia (2025). Mechanistic Insights into the Anti-Inflammatory and Anti-Proliferative Effects of Selected Medicinal Plants in Endometriosis. DOI: 10.3390/ijms262210947. PMCID: PMC12652039. PMID: 41303437. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12652039/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 5, 2026 by Migaku Evidence Review
